Clara D. Bloomfield

82.7k citations

406 papers · 42.9k indexed · 11 hit papers · h-index 91

Hematology top 0.01%
Molecular Biology top 0.1%
Genetics top 0.01%
Public Health, Environmental and Occupational Health top 0.02%
Oncology top 0.2%

Co-authors: James W. Vardiman Krzysztof Mrózek Michelle M. Le Beau Michael J. Borowitz Daniel A. Arber Hartmut Döhner Richard A. Larson Daniel J. Weisdorf
Topics: Acute Myeloid Leukemia Research (255 papers)Acute Lymphoblastic Leukemia research (129 papers)Chronic Myeloid Leukemia Treatments (92 papers)
Cited by: Hematology Genetics Cancer Research
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Lancet
Partner nations: United States Germany Italy

In The Last Decade

Clara D. Bloomfield

400 papers receiving 41.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2016 6.0k citations Attilio Orazi, Clara D. Bloomfield et al. Blood profile →
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

2009 3.0k citations James W. Vardiman, Jüergen Thiele et al. Blood profile →
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

1999 2.5k citations James W. Vardiman, Clara D. Bloomfield et al. Journal of Clinical Oncology profile →
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

2009 2.4k citations Hartmut Döhner, Elihu H. Estey et al. Blood profile →
Acute Myeloid Leukemia

2015 2.3k citations Hartmut Döhner, Clara D. Bloomfield et al. profile →
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

2003 1.9k citations Elihu H. Estey, Martin S. Tallman et al. Journal of Clinical Oncology profile →
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1997 806 citations Martin S. Tallman, Frederick R. Appelbaum et al. profile →
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

2007 604 citations Ayalew Tefferi, Jüergen Thiele et al. Blood profile →
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

2010 548 citations Guido Marcucci, Kati Maharry et al. Journal of Clinical Oncology profile →
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

1998 508 citations Clara D. Bloomfield, John C. Byrd et al. PubMed profile →
Acute myeloid leukaemia

2016 289 citations Clara D. Bloomfield, Alan K. Burnett et al. profile →

Peers

Countries citing papers authored by Clara D. Bloomfield

Since Specialization

Citations

This map shows the geographic impact of Clara D. Bloomfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara D. Bloomfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara D. Bloomfield more than expected).

Fields of papers citing papers by Clara D. Bloomfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara D. Bloomfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara D. Bloomfield. The network helps show where Clara D. Bloomfield may publish in the future.

Co-authorship network of co-authors of Clara D. Bloomfield

This figure shows the co-authorship network connecting the top 25 collaborators of Clara D. Bloomfield. A scholar is included among the top collaborators of Clara D. Bloomfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara D. Bloomfield. Clara D. Bloomfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia 2019 ·Molecular Cancer Therapeutics ·Dimitrios Papaioannou,Deedra Nicolet,Hatice Gülçin Özer,Krzysztof Mrózek,Stefano Volinia,Paolo Fadda,Andrew J. Carroll,Jessica Kohlschmidt,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,John C. Byrd,Ramiro Garzon,Clara D. Bloomfield	12
2	EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia 2019 ·Clinical Cancer Research ·Marius Bill,(unknown),Malith Karunasiri,Changxian Shen,(unknown),Parvathi Ranganathan,Dimitrios Papaioannou,Nina C. Zitzer,(unknown),(unknown),(unknown),(unknown),Ansel P. Nalin,Aharon G. Freud,Mikhail M. Dikov,Xiaoli Zhang,Clara D. Bloomfield,Ramiro Garzon,Adrienne M. Dorrance	20
3	Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category 2017 ·Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Alice S. Mims,Christopher J. Walker,James S. Blachly,Deedra Nicolet,Shelley Orwick,(unknown),Andrew J. Carroll,Bayard L. Powell,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	0
4	Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality 2016 ·Cancer Research ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Stefano Volinia,James S. Blachly,Deedra Nicolet,Christopher C. Oakes,(unknown),Shelley Orwick,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Albert de la Chapelle,Clara D. Bloomfield	16
5	Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia 2016 ·Cancer Discovery ·(unknown),Christopher J. Walker,Sandya Liyanarachchi,(unknown),(unknown),(unknown),Xiaomeng Huang,(unknown),(unknown),Parvathi Ranganathan,Ramiro Garzon,James S. Blachly,Denis C. Guttridge,Clara D. Bloomfield,Albert de la Chapelle,Ann‐Kathrin Eisfeld	13
6	MuCor: mutation aggregation and correlation 2016 ·Bioinformatics ·(unknown),(unknown),Gerard Lozanski,Clara D. Bloomfield,John C. Byrd,James S. Blachly	13
7	Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia 2013 ·Clinical Cancer Research ·Xiaomeng Huang,Sebastian Schwind,Bo Yu,Ramasamy Santhanam,Hongyan Wang,Pia Hoellerbauer,Alice S. Mims,Rebecca B. Klisovic,Alison R. Walker,Kenneth K. Chan,William Blum,Danilo Perrotti,John C. Byrd,Clara D. Bloomfield,Michael A. Caligiuri,Robert J. Lee,Ramiro Garzon,Natarajan Muthusamy,Ly James Lee,Guido Marcucci	151
8	Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study 2009 ·Journal of Clinical Oncology ·Heiko Becker,Guido Marcucci,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Dean Margeson,Susan P. Whitman,Yue-Zhong Wu,Sebastian Schwind,Peter Paschka,Bayard L. Powell,Thomas H. Carter,Jonathan E. Kolitz,Meir Wetzler,Andrew J. Carroll,Maria R. Baer,Michael A. Caligiuri,Richard A. Larson,Clara D. Bloomfield	241
9	Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetbreakdown → 2009 ·Blood ·Hartmut Döhner,Elihu H. Estey,Sergio Amadori,Frederick R. Appelbaum,Thomas Büchner,Alan K. Burnett,Hervé Dombret,Pierre Fenaux,David Grimwade,Richard A. Larson,Francesco Lo‐Coco,Tomoki Naoe,Dietger Niederwieser,Gert J. Ossenkoppele,Miguel Á. Sanz,Jorge Sierra,Martin S. Tallman,Bob Löwenberg,Clara D. Bloomfield	2350
10	Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study 2008 ·Journal of Clinical Oncology ·Guido Marcucci,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Tamara Vukosavljevic,Peter Paschka,Susan P. Whitman,Christian Langer,Claudia D. Baldus,Chang‐Gong Liu,Amy S. Ruppert,Bayard L. Powell,Andrew J. Carroll,Michael A. Caligiuri,Jonathan E. Kolitz,Richard A. Larson,Clara D. Bloomfield	224
11	Epigenetic Modification of CCAAT/Enhancer Binding Protein α Expression in Acute Myeloid Leukemia 2008 ·Cancer Research ·Björn Hackanson,Kristi L. Bennett,Romulo Martin Brena,Jinmai Jiang,Rainer Claus,Shih-Shih Chen,(unknown),(unknown),Susan P. Whitman,Thomas D. Schmittgen,Michael Lübbert,Guido Marcucci,Clara D. Bloomfield,Christoph Plass	114
12	DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication 2008 ·Blood ·Susan P. Whitman,Björn Hackanson,Sandya Liyanarachchi,Shujun Liu,Laura J. Rush,Kati Maharry,Dean Margeson,Ramana V. Davuluri,Jing Wen,(unknown),Li Yu,Chunhui Liu,Clara D. Bloomfield,Guido Marcucci,Christoph Plass,Michael A. Caligiuri	56
13	Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelbreakdown → 2007 ·Blood ·Ayalew Tefferi,Jüergen Thiele,Attilio Orazi,Hans Michael Kvasnicka,Tiziano Barbui,Curtis A. Hanson,Giovanni Barosi,Srđan Verstovšek,Gunnar Birgegård,Ruben A. Mesa,John T. Reilly,Heinz Gisslinger,Alessandro M. Vannucchi,Francisco Cervantes,Guido Finazzi,Ronald Hoffman,D. Gary Gilliland,Clara D. Bloomfield,James W. Vardiman	604
14	FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia 2007 ·Journal of Clinical Investigation ·Paolo Neviani,Ramasamy Santhanam,Joshua J. Oaks,Anna M. Eiring,Mario Notari,Bradley W. Blaser,Shujun Liu,Rossana Trotta,Natarajan Muthusamy,Carlo Gambacorti‐Passerini,Brian Druker,Jörge E. Cortes,Guido Marcucci,Ching-Shih Chen,Nicole M. Verrills,Denis‐Claude Roy,Michael A. Caligiuri,Clara D. Bloomfield,John C. Byrd,Danilo Perrotti	269
15	Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples 2006 ·International Journal of Oncology ·Wendy Stock,Daohai Yu,T. Karrison,Dorie Sher,Richard M. Stone,Richard A. Larson,Clara D. Bloomfield	21
16	Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics 2001 ·Proceedings of the National Academy of Sciences ·Kimmo Virtaneva,Fred A. Wright,Stephan M. Tanner,Bo Yuan,William J. Lemon,Michael A. Caligiuri,Clara D. Bloomfield,Albert de la Chapelle,Ralf Krahe	226
17	Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. 2001 ·PubMed ·Susan P. Whitman,Kellie J. Archer,Feng Lin,Claudia D. Baldus,Brian Becknell,(unknown),Jamie L. Carroll,Krzysztof Mrózek,J W Vardiman,Stephen L. George,(unknown),Richard A. Larson,Clara D. Bloomfield,M. A. Caligiuri	470
18	Combination trial of subcutaneous recombinant α₂b interferon and oral cyclophosphamide in follicular low‐grade non‐Hodgkin's lymphoma 1994 ·Medical and Pediatric Oncology ·Howard Ozer,James R. Anderson,B. A. Peterson,Daniel R. Budman,M. Robert Cooper,B. J. Kennedy,Richard T. Silver,Edward S. Henderson,David B. Duggan,(unknown),Clara D. Bloomfield,Arlan J. Gottlieb	11
19	Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. 1994 ·PubMed ·Michael A. Caligiuri,Steven A. Schichman,Matthew P. Strout,Krzysztof Mrózek,Maria R. Baer,Stanley R. Frankel,Maurice Barcos,Geoffrey P. Herzig,(unknown),Clara D. Bloomfield	119
20	Nonrandom chromosome abnormalities in lymphoma. 1983 ·PubMed ·Clara D. Bloomfield,Diane C. Arthur,Glauco Frizzera,Ellis G. Levine,B. A. Peterson,Kazimiera J. Gajl‐Peczalska	287

About Clara D. Bloomfield

Clara D. Bloomfield is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 406 papers that have together received 42.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (255 papers), Acute Lymphoblastic Leukemia research (129 papers) and Chronic Myeloid Leukemia Treatments (92 papers). The work is most often cited by research in Hematology (28.5k citations), Genetics (12.1k citations) and Cancer Research (5.3k citations). Clara D. Bloomfield has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include James W. Vardiman, Krzysztof Mrózek, Michelle M. Le Beau, Michael J. Borowitz, Daniel A. Arber, Hartmut Döhner, Richard A. Larson, Daniel J. Weisdorf, Guido Marcucci and Attilio Orazi. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact